Discover 272 paid clinical trials in Concord, New Hampshire. Search by condition or phase to find a research study near you that matches your needs across various therapeutic areas.
Filter
2
Filter results
Results: 272
Palazestrant in Combination With Ribociclib for the First-line Treatment of ER+/HER2- Advanced Breast Cancer
for
Breast Cancer, Locally Advanced Breast Cancer,
Location: Lebanon NH, Burlington MA, Scarborough ME, New Haven CT,
Sponsor: Olema Pharmaceuticals, Inc.
Sex: All
Age: 18+
Code: NCT07085767
Phase3, Recruiting
A Three-Part Phase 3 Study of Sofetabart Mipitecan in Participants With Platinum-Resistant (Part A) and Platinum-Sensitive (Parts B and C) Ovarian Cancer
Self-administered ONe-of-a Kind Approach to Epilepsy Therapy Through a Web-based Music Application
for
Epilepsy, Refractory Epilepsy, Music
Location: Lebanon NH
Sponsor: Dartmouth-Hitchcock Medical Center
Sex: All
Age: 18+
Code: NCT06425029
Recruiting
Once Daily Intrapleural Enzyme Therapy in Complicated Parapneumonic Effusion or Empyema
for
Pleural Infection Bacterial, Pleural Infections,
Location: Lebanon NH, New Haven CT, New York NY, Detroit MI,
Sponsor: University of North Carolina, Chapel Hill
Sex: All
Age: 18+
Code: NCT07095361
Recruiting
Internet Based Psychological Support
for
Depression, Stress, Conflict Resolution
Location: Lebanon NH
Sponsor: Dartmouth-Hitchcock Medical Center
Sex: All
Age: 18+
Code: NCT02726061
Recruiting
Real-Time Diagnosis of Life-Threatening Necrotizing Soft Tissue Infections (NSTI) Using Indocyanine Green (ICG) Kinetic Modeling
for
Necrotizing Fascitis
Location: Lebanon NH, Philadelphia PA, Ann Arbor MI, Nashville TN,
Sponsor: Eric R. Henderson
Sex: All
Age: 18+
Code: NCT06877793
Recruiting
An Open Label Extension (OLE) Study (Following Completion of CTQJ230A12301) to Evaluate Long-term Safety and Tolerability of Pelacarsen (TQJ230)
for
Cardiovascular Disease and Lipoprotein(a)
Location: Lebanon NH, Boston MA, Scarborough ME, Hartford CT,
Sponsor: Novartis Pharmaceuticals
Sex: All
Age: 18 - 70+
Code: NCT07517263
Phase3, Recruiting
Mirikizumab Administered at the Same Time as Tirzepatide in Adult Participants With Moderately to Severely Active Ulcerative Colitis and Obesity or Overweight: Phase 3b Study
for
Ulcerative Colitis, Obesity or Overweight
Location: Lebanon NH, Providence RI, New Bedford MA, Montreal,
Sponsor: Eli Lilly and Company
Sex: All
Age: 18 - 70
Code: NCT06937086
Phase3, Recruiting
Mirikizumab and Tirzepatide Administered in Adult Participants With Moderately to Severely Active Crohn's Disease and Obesity or Overweight
for
Crohn's Disease, Obesity or Overweight
Location: Lebanon NH, Providence RI, New Bedford MA, Montreal,